// App-Quantinova.ai

[SAT0384] : METFORMIN: A VALID ADD-ON DRUG IN THE TREATMENT OF PSORIATIC ARTHRITIS - RANDOMIZED CONTROLLED TRIAL

Researchers

Presenter

  • A. Abou-Raya

Principal Investigators

  • S. Abou-Raya

  • M. Helmii

Medical Centers

  • Clinical Chemistry,Medical Research Institute, Alexandria, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Systemic inflammation

  • Psoriatic arthritis

  • Metabolic syndrome

  • Diabetes

  • Inflammatory Arthritis

  • Psoriasis

  • Obesity

Biomarkers

  • AMP-activated protein kinase

  • C reactive protein

  • Estrogen receptor alpha

  • High sensitivity C-reactive protein

  • Interleukin 17A

  • Interleukin 6

  • Body mass index

  • Albumin/creatinine

Drug/Treatment

  • ILS-969

  • Methotrexate

  • Interleukin

  • FA-8

  • Prednisone

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved